Literature DB >> 16675905

Temocapril, an Angiotensin converting enzyme inhibitor, ameliorates age-related increase in carotid arterial stiffness in normotensive subjects.

Kunihiko Hayashi1, Koichi Miyagawa, Koichi Sato, Ryuzo Ueda, Yasuaki Dohi.   

Abstract

BACKGROUND/AIMS: Oxidative stress plays an important role in vascular ageing. The close relationship of the renin-angiotensin system with mechanisms of oxidative stress suggests its possible involvement in the deleterious effects of ageing. The present study was designed to investigate whether inhibition of the renin-angiotensin system improves the age-related increase in arterial stiffness.
METHODS: Normotensive elderly subjects in a geriatric nursing home (n = 24; male/female = 7/17; 86 +/- 9 years, mean +/- SD) were randomly assigned to receive either an angiotensin converting enzyme inhibitor, temocapril (n = 12, 1 mg daily) or nothing (n = 12). Carot id arterial stiffness parameter beta and circulating levels of malondialdehyde-modified low-density lipoprotein were measured before and 6 months after randomization.
RESULTS: Temocapril decreased beta (from 7.0 +/- 1.0 to 4.9 +/- 0.9, p < 0.05) and malondialdehyde-modified low-density lipoprotein levels (from 73.2 +/- 19.9 to 61.3 +/- 18.4 U/l, p < 0.05) without changing the blood pressure. The changes in beta and malondialdehyde-modified low-density lipoprotein levels were significantly correlated (rho = 0.600, p < 0.05).
CONCLUSION: These results suggest that temocapril ameliorates the age-related increase in carotid arterial stiffness in healthy, normotensive elderly subjects. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675905     DOI: 10.1159/000093024

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  8 in total

Review 1.  Mechanisms of vascular aging: new perspectives.

Authors:  Zoltan Ungvari; Gabor Kaley; Rafael de Cabo; William E Sonntag; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-06-24       Impact factor: 6.053

Review 2.  The role of the cell-matrix interface in aging and its interaction with the renin-angiotensin system in the aged vasculature.

Authors:  Maria De Luca
Journal:  Mech Ageing Dev       Date:  2018-04-04       Impact factor: 5.432

Review 3.  Aerobic exercise and other healthy lifestyle factors that influence vascular aging.

Authors:  Jessica R Santos-Parker; Thomas J LaRocca; Douglas R Seals
Journal:  Adv Physiol Educ       Date:  2014-12       Impact factor: 2.288

Review 4.  Nutrition and other lifestyle influences on arterial aging.

Authors:  Thomas J LaRocca; Christopher R Martens; Douglas R Seals
Journal:  Ageing Res Rev       Date:  2016-09-28       Impact factor: 10.895

Review 5.  Mechanisms of Vascular Aging.

Authors:  Zoltan Ungvari; Stefano Tarantini; Anthony J Donato; Veronica Galvan; Anna Csiszar
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

6.  Vascular stiffness and increased pulse pressure in the aging cardiovascular system.

Authors:  Jochen Steppan; Viachaslau Barodka; Dan E Berkowitz; Daniel Nyhan
Journal:  Cardiol Res Pract       Date:  2011-08-02       Impact factor: 1.866

Review 7.  A low-dose combination of fluvastatin and valsartan: a new "drug" and a new approach for decreasing the arterial age.

Authors:  Miodrag Janić; Mojca Lunder; Mišo Šabovič
Journal:  Biomed Res Int       Date:  2015-03-03       Impact factor: 3.411

Review 8.  Endogenous Vasoactive Peptides and Vascular Aging-Related Diseases.

Authors:  Yao Chen; Yongfen Qi; Weiwei Lu
Journal:  Oxid Med Cell Longev       Date:  2022-10-03       Impact factor: 7.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.